The Management Board of Genomtec S.A. is pleased to inform that the series J share price has been set at PLN 11 per share. The issuing shares’ price is therefore equal to the maximum price published in the Memorandum.
It is noted that investors have noticed a tremendous potential and innovation of the Genomtec ID mobile diagnostic genetic platform, which has been reflected in the huge investors’ interest. The overall declaration for the intended shares purchase has been achieved for the amount exceeding 50 million PLN. The Company sincerely thanks all Investors for the trust received and is delighted to be able to proceed successfully with the initial public offering so promptly. This fact makes commercialization of the Genomtec ID platform credible as planned.
Due to an extensive interest registered for the book-building process, the Company has announced an updated share issue schedule. Since 26th to 28th October 2020 the shares subscribes’ invitations have been sent to all prospective investors that took part in the book building. Since 26th October to 2nd November 2020 chosen subscriptions and resulting payments for shares allocation will be carried.
